4//SEC Filing
Miller Matthew P 4
Accession 0001628280-23-008832
CIK 0001799191other
Filed
Mar 20, 8:00 PM ET
Accepted
Mar 21, 8:56 PM ET
Size
7.8 KB
Accession
0001628280-23-008832
Insider Transaction Report
Form 4
Miller Matthew P
Chief Operating Officer
Transactions
- Award
Common stock
2023-03-17+67,667→ 242,992 total - Award
Non-Qualified Stock Option (right to buy)
2023-03-17+169,169→ 169,169 totalExercise: $0.48Exp: 2033-03-17→ Common stock (169,169 underlying)
Footnotes (2)
- [F1]Represents RSUs with 1/4th of the RSUs vesting on the anniversary of March 17, 2023 (the Vesting Commencement Date), with the remaining RSUs vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all RSUs becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates.
- [F2]The stock options vest as to 1/4th of the options granted on the first anniversary of the Vesting Commencement Date, with the remaining options vesting in four equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all options becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates.
Documents
Issuer
Oncology Institute, Inc.
CIK 0001799191
Entity typeother
Related Parties
1- filerCIK 0001915822
Filing Metadata
- Form type
- 4
- Filed
- Mar 20, 8:00 PM ET
- Accepted
- Mar 21, 8:56 PM ET
- Size
- 7.8 KB